OAKLAND, Calif., Oct. 23, 2013 /PRNewswire/ --Three Kaiser Permanente Colorado researchers have been named co-recipients of the prestigious Drug Therapy Research Literature Award, an award presented annually by the American Society of Health-System Pharmacists Foundation.
Daniel Witt, PharmD, FCCP, BCPS, Tom Delate, PhD, MS, and Nathan Clark, PharmD, FCCP, BCPS, co-wrote the award-winning article titled "Risk of Thromboembolism, Recurrent Hemorrhage and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding," which initially appeared in JAMA Internal Medicine, a peer-reviewed medical journal formerly called Archives of Internal Medicine, in 2012. It was selected among "pretty formidable competition," according to ASHP Foundation Vice President Daniel J. Cobaugh.
The ASHP Foundation Literature Awards Program honors important contributions by pharmacists to the biomedical literature. The Literature Awards are made to individuals who publish high-impact articles in the primary, peer-reviewed, biomedical literature. Emphasis is placed on originality, innovation, impact and quality of the contributed articles. The ASHP Foundation will recognize this year's Literature Award winners during its midyear clinical meeting in Orlando, Fla., on Dec. 11.
"At Kaiser Permanente, one of our goals is to improve medication safety for our patients, and this award is validation that we are achieving that goal," said David Kvancz, vice president, National Pharmacy Programs and Services for Kaiser Permanente. "We strive to publish research that helps clinicia
|SOURCE Kaiser Permanente|
Copyright©2012 PR Newswire.
All rights reserved